Cerebrospinal Fluid, Imaging, and Physiological Biomarkers in Dementia With Lewy Bodies

被引：9
|
作者：
Mavroudis, Ioannis [1 ]
Petridis, Foivos [2 ]
Kazis, Dimitrios [2 ]
机构：
[1] Leeds Teaching Hosp, Dept Neurol, Leeds LS9 7TF, W Yorkshire, England
[2] Aristotle Univ Thessaloniki, Dept Neurol 3, Thessaloniki, Greece
来源：
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS | 2019年 / 34卷 / 7-8期
关键词：
dementia with Lewy bodies; biomarkers; CSF; physiological; neuroimaging; PARKINSONS-DISEASE DEMENTIA; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN LEVELS; TEMPORAL-LOBE ATROPHY; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; DIFFERENTIAL-DIAGNOSIS; I-123-FP-CIT SPECT;
D O I：
10.1177/1533317519869700
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Dementia with Lewy bodies is a progressive neurodegenerative disorder, clinically characterized by gradual cognitive impairment and fluctuating cognition, behavioral changes and recurrent visual hallucinations, and autonomic function and movement symptoms in the type of parkinsonism. It is the second most common type of dementia in the Western world after Alzheimer disease. Over the last 20 years, many neurophysiological, neuroimaging, and cerebrospinal fluid (CSF) biomarkers have been described toward a better discrimination between dementia with Lewy bodies, Alzheimer disease, and other neurodegenerative conditions.In the present review, we aim to describe the neurophysiological, imaging, and CSF biomarkers in dementia with Lewy bodies and to question whether they could be reliable tools for the clinical practice.
引用
收藏
页码：421 / 432
页数：12
相关论文
共 50 条
  • [1] Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
    Foska, Aikaterini
    Tsantzali, Ioanna
    Sideri, Eleni
    Stefanou, Maria Ioanna
    Bakola, Eleni
    Kitsos, Dimitrios K.
    Zompola, Christina
    Bonakis, Anastasios
    Giannopoulos, Sotirios
    Voumvourakis, Konstantinos I.
    Tsivgoulis, Georgios
    Paraskevas, George P.
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [2] Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
    Parnetti, Lucilla
    Tiraboschi, Pietro
    Lanari, Alessia
    Peducci, Maria
    Padiglioni, Chiara
    D'Amore, Cataldo
    Pierguidi, Laura
    Tambasco, Nicola
    Rossi, Aroldo
    Calabresi, Paolo
    BIOLOGICAL PSYCHIATRY, 2008, 64 (10) : 850 - 855
  • [3] α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
    van Steenoven, Inger
    Majbour, Nour K.
    Vaikath, Nishant N.
    Berendse, Henk W.
    van der Flier, Wiesje M.
    van de Berg, Wilma D. J.
    Teunissen, Charlotte E.
    Lemstra, Afina W.
    El-Agnaf, Omar M. A.
    MOVEMENT DISORDERS, 2018, 33 (11) : 1724 - 1733
  • [4] ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium
    Jain, Lavanya
    Khrestian, Maria
    Formica, Shane
    Tuason, Elizabeth D.
    Pillai, Jagan A.
    Rao, Stephen
    Oguh, Odinachi
    Lippa, Carol F.
    Lopez, Oscar L.
    Berman, Sarah B.
    Tsuang, Debby W.
    Zabetian, Cyrus P.
    Irwin, David J.
    Galasko, Douglas R.
    Litvan, Irene
    Marder, Karen S.
    Honig, Lawrence S.
    Fleisher, Jori E.
    Galvin, James E.
    Bozoki, Andrea C.
    Taylor, Angela S.
    Sabbagh, Marwan N.
    Leverenz, James B.
    Bekris, Lynn M.
    ALZHEIMERS & DEMENTIA, 2024, 20 (01) : 549 - 562
  • [5] Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
    M. van de Beek
    R. Babapour Mofrad
    I. van Steenoven
    H. Vanderstichele
    P. Scheltens
    C. E. Teunissen
    A. W. Lemstra
    W. M. van der Flier
    Alzheimer's Research & Therapy, 12
  • [6] Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
    van de Beek, M.
    Mofrad, R. Babapour
    van Steenoven, I.
    Vanderstichele, H.
    Scheltens, P.
    Teunissen, C. E.
    Lemstra, A. W.
    van der Flier, W. M.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [7] Conventional Alzheimer's biomarkers in cerebrospinal fluid are not pathological in patients with prodromal dementia with Lewy bodies
    Bousiges, Olivier
    Donaghy, Paul
    Blanc, Frederic
    Thomas, Alan
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 : S29 - S30
  • [8] VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
    van Steenoven, Inger
    Noli, Barbara
    Cocco, Cristina
    Ferri, Gian-Luca
    Oeckl, Patrick
    Otto, Markus
    Koel-Simmelink, Marleen J. A.
    Bridel, Claire
    van der Flier, Wiesje M.
    Lemstra, Afina W.
    Teunissen, Charlotte E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [9] Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
    Parnetti, L.
    Balducci, C.
    Pierguidi, L.
    De Carlo, C.
    Peducci, M.
    D'Amore, C.
    Padiglioni, C.
    Mastrocola, S.
    Persichetti, E.
    Paciotti, S.
    Bellomo, G.
    Tambasco, N.
    Rossi, A.
    Beccari, T.
    Calabresi, P.
    NEUROBIOLOGY OF DISEASE, 2009, 34 (03) : 484 - 486
  • [10] Molecular imaging biomarkers for dementia with Lewy bodies: an update
    Mukaetova-Ladinska, Elizabeta B.
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (04) : 555 - 577
12345